Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis

BACKGROUND: The systemic immune-inflammation index (SII) represents the immunoinflammatory score and can be considered as a prognostic marker; however, its relevance to the prognosis in patients with diffuse large B-cell lymphoma (DLBCL) remains unclear. OBJECTIVES: The present meta-analysis was con...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zaijing, Shou, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Recent Advances in Immunotherapy for Lymphoma and Multiple Myeloma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638869/
https://www.ncbi.nlm.nih.gov/pubmed/37954483
http://dx.doi.org/10.1177/20406207231208973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638869/
https://www.ncbi.nlm.nih.gov/pubmed/37954483
http://dx.doi.org/10.1177/20406207231208973

Ejemplares similares